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Introduction
For many years, Japanese and Korean surgeons have emphasized the importance of major gastrectomies with extensive lymphadenectomies as a part of curative treatment for gastric cancer. Nowadays, however, they perform minor procedures for these malignancies, thus individualizing gastric cancer treatment.
This has been possible due to early diagnosis of gastric cancer in those countries, as surgery for patients with early gastric cancer (EGC) has accounted for more than 50% of all surgical procedures for gastric cancer in these countries. Minor procedures include endoscopic resections and minor gastric resections with less extensive lymphadenectomies, such as D1 or modified D1, and have improved postoperative quality of life while maintaining 5-year survival rates above 95%. 1, 2 The high gastric cancer what has led to expanded indications for endoscopic resections and supported the idea of sentinel node (SN) navigation surgery (SNNS) for EGC. [3] [4] [5] [6] This study aims to evaluate the outcomes of patients with EGC who underwent SNNS as a primary surgery in a university hospital in Brazil, a country with high, but still non-endemic, rates of gastric cancer.
Materials and Methods
We 
Results
Among the 14 patients, there were 6 female and 8 male patients aged between 36 and 83 years, with an average age of 64. with no evidence of recurrence. Two patients were diagnosed with a second EGC, 1 and 2 years after surgery, and underwent total gastrectomies with D2 lymphadenectomies. In both cases, all removed lymph nodes were disease free (Table 1) .
Discussion
Lymph node metastases in gastric cancer patients are frequent, But SNNS still has some issues, such as false-negative results on histological examination of sentinel lymph nodes, the possibility of undetected micrometastases in frozen section biopsies performed with hematoxylin and eosin staining, and the occurrence of skip metastases. [7] [8] [9] [10] [11] [12] [13] These problems may be minimized using new available methods, for instance those that allow quick detection of micrometastases in the operating room through semi-automated molecular-based rapid diagnostic methods that detect lymph node metastases using one-step nucleic acid amplification. 14 The significance of these micrometastases for prognosis also needs to be better evaluated, but the possibility of making diagnoses intraoperatively is a reality and will soon become routine worldwide. Because the incidence of skip metastases is less than 3% and mostly occurs in lymph nodes stations 7, 8, and 9, some authors suggest that lymphadenectomies should be extended to those stations depending on the location of the tumor. 1, 10, 15, 16 Taking all these points into consideration, it is important to emphasize that pick-up biopsies of SNs are inadequate and risky, and basin resection should be considered mandatory for SNNS. 17 In Western countries, where gastric cancer incidence has decreased over the years and early diagnosis is still the exception, treatment outcomes for gastric cancer patients are still poor and are reflected in the overall 5-year stage-specific survival rates that have been consistently superior in studies from Japan and Korea when compared with large Western trials. These differences are due to many factors, but we would like to emphasize stage migration and differences in tumor biology, as Chen et al.
recently described. 18 The rate of EGC lymph node metastasis in our previous study, for instance, was higher than that observed in East Asian countries. In this recently published study of 178 patients treated for gastric cancer, 27 patients (15.2%) were diagnosed with EGC, and almost 30% of them already had lymph node metastases. 19 This rate ranged from 15.4% for patients with tumors restricted to the mucosa (T1a) to 42.8% for patients with tumors with submucosal involvement (T1b). Despite the small number of cases, these data made the decision to conduct SNNS for EGC difficult and emphasized our decision to extend basin resection to other lymph node stations in patients with moderately and poorly differentiated tumors since these were the most important risk factors for lymph node metastasis in our study. On the other hand, more than two-thirds of our EGC cases involved patients with other serious diseases, including portal hypertension, since the majority of EGC was diagnosed from findings of endoscopic procedures performed to complement other diagnostic evaluations. Extended gastrectomies and lymphadenectomies in gastric cancer patients with cirrhosis can lead to severe postoperative morbidity and mortality. Choosing the appropriate surgical strategy in such cases is still controversial. 20 Minor surgeries for these patients should always be considered.
In 2012, we published our first seven cases of EGC for which we performed minor gastric resections with sentinel basin resec-tions in patients undergoing sentinel lymph node mapping using patent blue dye. 21 Our current study examines 14 patients, with two deaths from causes unrelated to gastric cancer. There was one postoperative death from liver failure in a cirrhotic patient, and another cirrhotic patient died also from liver failure after two years without gastric cancer recurrence. All other patients were followed up for 13 to 79 months with no evidence of recurrence. Among these 12 cases, one patient received a falsenegative result from SN biopsies (8.3%), and another patient had micrometastases in two of the resected nodes (8.3%). Since we always resect all SN stations and all other lymph nodes from other resected stations were negative for metastasis, we chose not to reoperate on the patients. In our study, we decided that sentinel basin resections would be performed in four patients with well- Some authors have demonstrated that patients with gastric cancer without lymph node metastases but with limited invasion of the muscularis propria had similar outcomes to those with EGC, with similarly good prognoses. 22 The absence of serosal involvement also suggested that peritoneal carcinomatosis were unlikely. In a large Japanese study, patients preoperatively staged as cT1N0 that were postoperatively diagnosed as pT2N0, had better prognoses, lower N staging and limited lymph node metastasis in 98% of cases. Five-year survival rates were greater than those with preoperative diagnoses of T2 advanced tumors. 23, 24 For patient 12, a 36-year-old man with a 2-cm type III poorly differentiated tumor who received a false-negative result from SN biopsies and was postoperatively staged T3N1M0, we decided to administer adjuvant radiotherapy and chemotherapy. Two of our patients (cases 3 and 4) had second early tumors found on endoscopy scans performed 1 and 2 years after surgery, and we chose to complete gastrectomies in those cases.
Metachronous gastric tumors after resection of EGC occurred in approximately 3% of patients in a large Japanese study of 1,281
cases, but in a smaller study of patients undergoing EGC laparoscopic wedge resection, this rate reached 12%. 26, 27 The main independent risk factors revealed from multivariate analysis were male gender, advanced age, invasion of the submucosa, and proximal gastrectomy. Leaving an almost entire stomach after these minor resections results in an additional risk for a second EGC that often occurs within the first two postoperative years.
Patent blue, lymphazurin, and the indocyanine green (ICG) are preferable dyes for SN mapping and are widely used due to the cost effectiveness. They can detect lymphatic vessels as well as lymph nodes, but they may not be suitable for obese patients who have dense adipose tissue, which would cause a high falsenegative rate. ICG dye seems to be more suitable for SNNS due to its high accuracy, but it is poorly visible compared to blue dyes. The use of infrared ray electronic endoscopy combined with ICG; however, may overcome those visibility problems, and stained nodes can also be identified through dense adipose tissues when using this method. [28] [29] [30] Sometimes radioisotopes are used to increase sensitivity of node identification. In our study, patent blue dye injected intraoperatively through endoscopy identified SNs in 100% of patients. There were no allergic reactions to the blue dye.
Patent blue dye was chosen mainly because of its cost effectiveness.
Although still yielding controversial results that range from a false-negative rate of 46.4% for biopsies 13 to a 99% accuracy for evaluation of metastatic EGC status, 28 SNNS will probably soon be an attractive tool to detect clinically undetectable lymph node metastasis of EGC. 29 Laparoscopic sentinel basin dissection is be-coming more safe and more feasible according to well-conducted prospective multicenter studies and will allow safe organ preserving surgeries for gastric cancer. 17 Although our small patient sample revealed unexpected variables, the complete absence of tumor recurrence suggests that SNNS is a safe procedure in a country with non-endemic gastric cancer levels and will probably be a safe option for treatment in the near future. Especially if associated with minimally invasive surgery, this procedure may ensure better quality of life, low rates of postoperative complications, and shorter hospital stays for many patients. It is urgent to increase histological examination accuracy of SN frozen sections in order to reduce the risk of false-negative results as well as to identify micrometastases.
